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Abstract
We investigated the presence of antibiotics in cryopreserved cardiovascular tissues and cryopreservation media, after tissue
decontamination with antibiotic cocktails, and the impact of antibiotic residues on standard tissue bank microbiological
analyses. Sixteen cardiovascular tissues were decontaminated with bank-prepared cocktails and cryopreserved by two
different tissue banks according to their standard operating procedures. Before and after decontamination, samples
underwent microbiological analysis by standard tissue bank methods. Cryopreserved samples were tested again with and
without the removal of antibiotic residues using a RESEP tube, after thawing. Presence of antibiotics in tissue homogenates
and processing liquids was determined by a modified agar diffusion test. All cryopreserved tissue homogenates and
cryopreservation media induced important inhibition zones on both Staphylococcus aureus- and Pseudomonas aeruginosa-
seeded plates, immediately after thawing and at the end of the sterility test. The RESEP tube treatment markedly reduced or
totally eliminated the antimicrobial activity of tested tissues and media. Based on standard tissue bank analysis, 50% of
tissues were found positive for bacteria and/or fungi, before decontamination and 2 out of 16 tested samples (13%) still
contained microorganisms after decontamination. After thawing, none of the 16 cryopreserved samples resulted positive
with direct inoculum method. When the same samples were tested after removal of antibiotic residues, 8 out of 16 (50%)
were contaminated. Antibiotic residues present in tissue allografts and processing liquids after decontamination may mask
microbial contamination during microbiological analysis performed with standard tissue bank methods, thus resulting in
false negatives.
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Introduction
Tissue banks, including cardiovascular tissue banks, procure,
process, store, and distribute human donor tissues intended for
transplantation. The main clinical applications of heart valve
allografts include valve replacement in patients with congenital or
acquired heart disease and substitution of infected heart valve
prosthesis [1,2]. Vascular allografts are used for vascular
reconstruction, revascularization in absence of autogenic veins in
patients with idiopathic or diabetic vasculopathies, and replace-
ment of infected vascular prosthesis [1,3].
Decontamination is a critical phase of the processing of human
tissues intended for transplantation. Tissue banks worldwide have
established a wide variety of homemade antibiotic cocktails and
procedures to eliminate microbial contaminants from tissues to
maximize the safety of allografts [2,4–6]. Tissue decontamination
may result in the presence of antibiotic residues in both
decontaminated tissues and processing liquids [7].
Residual antibiotic concentrations may induce bacteriostasis of
microorganisms eventually present on tissue samples and lead to
false negative results during microbiological analysis [8]. Accord-
ing to the European and US Pharmacopoeias [9,10], the sterility
test must be preceded by complete removal of any possible
interfering antimicrobial agents.
No specific standards for microbiological analysis in tissue
banking are available. Consequently, each tissue bank shall
validate the method for tissue and liquid sample microbiological
analysis, which is essential to determine whether the tissue can be
released for transplantation [11–13]. The microbiological analysis
is usually performed by means of automated blood culture systems
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or direct inoculum of growth media [13,14]. In general, these
systems do not consider the presence of high antibiotic residues in
tissues and processing liquids after decontamination, which is a
possible cause of falsely negative microbiological results. This
problem is further underestimated by the general assumption that
antibiotics are rapidly degraded during the sustained tissue
incubations necessary for sterility assessment.
To investigate the impact of antibiotic residues on microbio-
logical analysis, we used human cardiovascular tissues, decontam-
inated with different antibiotic cocktails, two tissue bank micro-
biological methods and the RESEP tube method, which has been
previously validated for the elimination of antibiotics from tissues
and processing liquids, decontaminated with an industrial cocktail.
All cryopreserved samples tested for sterility were also analyzed for
the presence of antibiotic activity by a modified agar diffusion
method.
Materials and Methods
Ethics statement
Donor tissues were collected and processed in compliance with
the European Directives on setting quality standards and technical
requirements for the processing of human tissues and cells. Only
tissues unsuitable for transplantation were used for the study, and
the permission was granted by the institutional review board of the
Cardiovascular Tissue Bank of Emilia Romagna (CTBER) and the
Cardiovascular Tissue Bank of Lombardia (CTBL). All clinical
investigation has been conducted according to the principles
expressed in the Declaration of Helsinki.
Tissues procurement and processing
Sixteen human cardiovascular tissues (5 aortic heart valves and
11 blood vessels graded as unsuitable for transplantation due to
anatomical defects) were included in the study. Six and 10 tissues
were collected and processed by CTBER and CTBL, respectively.
Tissues were transported to the tissue banks at 4uC in antibiotic-
free transport media, Celsior (Genzyme Europe BV, Netherlands;
CTBER) or Eurocollins (S.A.L.F. S.p.A., Italy; CTBL), and
processed following tissue bank standard operating procedures. In
particular, tissue were decontaminated with tissue bank-prepared
antibiotic cocktails, containing cefoxitin, lincomycin, colimycin,
vancomycin in RPMI1640 (cocktail 1, CTBER) or cefotaxime,
lincomycin, vancomycin, polymyxin B sulfate in RPMI1640
(cocktail 2, CTBL) at 4uC for 24 h (valves) and 72 h (vessels).
Tissues were then rinsed twice for 1 min with NaCl 0.9% (only for
CTBER) and finally cryopreserved in RPMI 1640 (Sigma-Aldrich,
St. Louis, MO, USA) containing 10% DMSO (Wak-Chemie,
Germany), using programmable freezers with freezing rate of
21uC/min. The CTBER cryopreservation solution also contained
2% human albumin (Kedrion Biopharmaceuticals, Italy). Cryo-
preserved samples were then transported in dry ice to the R&D
department of AL.CHI.MI.A. S.r.l. for further microbiological
analysis and detection of antibiotic residues.
Microbiological analysis
Microbiological analysis of samples collected from processing
liquids and tissues, before and after decontamination, was
performed by the tissue banks, according to their standard
operating procedures. At CTBER, 5 ml of the transport and
cryopreservation solutions were introduced in the BacT/ALERT
vials to detect aerobic and anaerobic bacteria and incubated at
37uC in the BacT/ALERT 3D automatic detection system
(Biome´rieux, France) for 5 days. Tissue samples were immersed
in fluid thioglycollate medium (FTM) and tryptic soy broth (TSB)
and incubated at 35uC for 7 days (direct inoculum method). At
CTBL, 1 ml of transport and cryopreservation solutions and tissue
samples were introduced in FTM and incubated at 37uC for 7
days (direct inoculum method). At R&D department of AL.CHI.
MI.A S.r.l., 5 ml of thawed cryopreservation solutions and tissue
samples were tested by incubation in TSB and FTM at 24uC and
33uC for 14 days, respectively (direct inoculum method, according
to the European Pharmacopoeia [9]). In addition, separate
samples from same solutions and tissues were introduced in the
RESEP tube (AL.CHI.MI.A. S.r.l., Italy) containing a specific
resin mixture, which was expressly formulated to eliminate the
antibiotics contained in the BASE.128 decontamination medium
(AL.CHI.MI.A. S.r.l., Italy). The RESEP tubes were filled with
TSB and FTM and incubated at 24uC and 33uC for 14 days,
respectively. Samples were considered contaminated (positive)
when growth media appeared turbid at visual inspection as
compared to sterile growth media (negative control), or when
reported by the automatic system BacT/ALERT 3D. The
presence of microorganisms in turbid samples was confirmed by
subculture on agar plates or in fresh culture media.
Detection of antibiotic residues in tissue homogenates
and cryopreservation media
Six cryopreserved tissue samples and cryopreservation media
for each bank-prepared antibiotic cocktail were evaluated for
antibiotic content, as previously described [7]. The agar diffusion
test was adapted for the detection of antibiotics in tissue
homogenates and cryopreservation media samples using Staphy-
lococcus aureus ATCC6538 (SA)-, Pseudomonas aeruginosa
ATCC 9027 (PA)-, and Candida albicans ATCC10231 (CA)-
seeded agar plates. Each tissue homogenate and cryopreservation
medium was assessed at least in triplicate for each microbial strain.
Cryopreservation media and homogenates of six tissues decon-
taminated with BASE.128 and cryopreserved according to CTBL
method were used as a control. For both the direct inoculum and
RESEP tube methods, antibiotic activity of tissue samples was
evaluated immediately after tissue thawing and at the end of the
14-day sterility testing; antibiotic activity of cryopreservation
media was assessed immediately after thawing and after inocula-
tion in culture broths. Antibiotic-free cryopreservation medium
and 10% BASE.128 solution plated on each microorganism
seeded agar plate served as negative and positive control,
respectively.
Statistics
Tissue homogenates and cryopreservation media were grouped
on the basis of antibiotic cocktail treatment (cocktail 1, cocktail 2,
and BASE.128), and the mean inhibition zone diameters and
standard errors were calculated for each microbial strain (SA, PA,
CA).
Results
Presence of residual antibiotics in cryopreserved tissues
and cryopreservation solutions
Immediately after thawing, all cryopreserved tissues homoge-
nates, decontaminated with different antibiotic cocktails, induced
similar inhibition zones in the range of 10.0–10.4 mm on SA-
seeded plates. On the last day of sterility testing period, all tissues
still induced 3.7–4.4 mm inhibition zones on SA plates.
Antibiotic elimination from tissue samples with the RESEP tube
reduced inhibition zones by 81%–98% and 94%–100% on initial
and final day of the 14-day sterility testing period, respectively
(Figure 1A). Similarly, all cryopreservation media inhibited the
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growth of SA on agar plates. Cocktail 1, cocktail 2, and BASE.128
residues induced 11.2-, 6.9-, and 7.1-mm inhibition zones on SA
plates, respectively. All cryopreservation media inoculated in
growth broths induced detectable SA inhibition activity that was
totally abolished by the RESEP tube treatment (Figure 1A).
The width of inhibition zones on PA-seeded plates varied
depending on the antibiotic cocktail used during tissue decontam-
ination. Immediately after thawing, 1.5- and 8.6-mm zones were
induced by cocktail 1- and cocktail 2-treated tissues, respectively.
After the 14-day sterility testing period, cocktail 2-treated tissues
still induced 6.6-mm inhibition zones, whereas cocktail 1- and
BASE.128-treated tissues induced 0.3- and 1.1-mm inhibition
zones on PA-seeded plates, respectively (Figure 1B).
The growth of PA on agar plates was also inhibited by all
cryopreservation media. Cocktail 2 residues induced the largest
inhibition zones (5.8 mm) on PA plates and 1.9-mm inhibition
zones were still detected after inoculation of cryopreservation
media in growth broths.
Inhibition zones of the RESEP tube-treated tissues and solutions
were markedly reduced or absent on PA plates except for cocktail
2-treated tissues, which induced detectable inhibition zones despite
the RESEP treatment (Figure 1B).
Inhibition zones were not detected on antimycotic-sensible CA
plates for any investigated tissue homogenate or cryopreservation
medium at any tested time point (Table S1).
Microbiological analysis
Tissue bank microbiological analysis of tissue samples and
transport solution showed that 50% of the tissues were initially
contaminated. These mostly corresponded to the blood vessels
donated after cardiac death, collected by CTBER and were
detected in both tissue and liquid samples. In CTBL, which
Figure 1. Presence of antibiotic residues in decontaminated and cryopreserved tissue homogenates and cryopreservation media.
Agar diffusion assays performed using Staphylococcus aureus-seeded plates (A) and Pseudomonas aeruginosa-seeded plates (B), immediately after
thawing (initial) and after 14 days of sterility testing (final) on tissues and media undergoing decontamination procedures with Cocktail 1 and Cocktail
2, prepared by tissue banks, and BASE.128 as a control. The plot legend on Figure 1A also applies to Figure 1B.
doi:10.1371/journal.pone.0112679.g001
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procured tissues only from brain death donors, the initial
contamination rate was 30% and contaminants were recovered
exclusively from transport liquid samples (Table 1). Approximately
half of the contaminated tissues were contaminated with S.
epidermidis. The remaining contaminants were represented by
other bacterial strains, including Enterobacter cloacae, Enterococ-
cus faecalis, Escherichia coli, Streptococcus mitis, Streptococcus
viridans, Corynebacterium spp. and Bacillus spp. One tissue was
contaminated with C. albicans (Table S2).
After decontamination, 2 out of 6 samples tested by CTBER
were still found positive for bacterial and fungal contaminants.
One of these contaminations (C. albicans) was detected with the
direct inoculum method on tissue sample and the other (E. coli)
with the Bactalert method on liquid sample (Table 1). All samples
tested by CTBL resulted negative after decontamination.
After thawing, the microbiological analysis of cryopreserved
tissue samples and solutions performed with the direct inoculum
method, i.e., in the presence of antibiotic residues, did not detect
contamination in any of the tested tissue or liquid samples.
Microbiological analysis of cryopreserved tissue samples and
solutions performed after removal of antibiotic residues with the
ResEP tube showed that 5 out of 10 (50%) CTBL samples and 3
out of 6 (50%) CTBER samples were positive. Altogether, RESEP
method detected contaminations in 8 tissue samples and 5 related
cryopreservation solutions (Table 1).
Discussion
We used a fast and simple modified agar diffusion method that
allowed us to detect rapidly the presence of antibiotics in tissue
homogenates and cryopreservation media at different time points
of sterility testingwithout the need for additional extraction
methods. We showed that the significant levels of antibiotic
residues can be detected in decontaminated cardiovascular tissues
and processing liquids after thawing, despite rinsing and
cryopreservation. In fact, antimicrobial activity against both
gram-positive and gram-negative bacteria was detected by SA-
and PA-seeded plates, which varied depending on decontamina-
tion cocktail and protocol. We speculate that inhibition zones
induced by cocktail 2, particularly marked on PA-seeded plates,
were due to different composition and higher concentration of
antibiotics active against PA. The absence of inhibition zones on
CA-seeded plates confirmed that the tested samples did not
contain antimycotics, as expected for tissues treated with bank-
prepared cocktails lacking such components. Similarly, no
inhibition zones on CA-seeded plates were observed for control
tissues treated with BASE.128, indicating no carry-over of
amphotericin B deoxycholate in tissue and liquid samples.
Consistently with a previous paper [7], the antibiotics were not
only present in tissue homogenates, but also transferred from
tissues to cryopreservation liquids and sterility test growth broths,
where they remained active for up to 14 days of sample
incubation. This strongly argues against the assumption that
antibiotics are efficiently degraded under the standard conditions
of microbiological analysis. Moreover, although some antibiotics
such as beta-lactam antibiotics (cefoxime and cefotaxime) are
relatively labile, others, including polymyxin B, lincomycin,
vancomycin, and gentamicin, are stable enough to induce
bacteriostatic effects under these conditions, which is in accor-
dance with our results.
Our study highlighted a possible issue of validity of the
microbiological method used for detection of microbial contam-
inations in tissue banking due to the presence of antibiotic residues
in the tested samples.
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Tissue samples decontaminated with antibiotic cocktails are a
specific type of microbiological sample that may present bacterio-
static and/or fungistatic properties [8,15]. The intrinsic properties
of the tissues, such as enzymatic activity, immunologic events, and
presence of antimicrobial peptides [16], which are well described
in the skin [17], cornea [18], and amniotic membrane [19], may
be exacerbated by the presence of residual antibiotics following
tissue decontamination with antibiotic cocktails [7,8,20]. The
European and US Pharmacopoeias indicate eliminating any factor
that may interfere with microbial growth during sterility testing
from samples [9,10].
In our study, the microbiological negativity of 14 out of 16
(88%) tissue and liquid samples was observed by standard tissue
bank methods, after decontamination. The two bank-prepared
cocktails used in the present study intentionally do not contain
antimycotics and this may explain both the persistence of fungal
contamination found in one tissue sample, despite the decontam-
ination procedure, and its recovery by the direct inoculum method
performed by the tissue banks. Fungal contaminations account for
approximately 1% of total contaminations and correspond to the
expected tissue discard rate of the two tissue banks.
All cryopreserved tissue and cryopreservation solution samples
resulted negative with the direct inoculum method in the absence
of antibiotics removal, whereas 50% of these samples resulted
positive when tested with the RESEP tube method that comprises
antibiotic residue removal. This clearly shows the false negative
results obtained by the direct inoculum method.
Some automatic blood culture systems implement antibiotic
neutralization features. However, they were specifically designed
and validated for blood samples [13,21], where the expected
antibiotic concentrations are relatively low. Therefore, the
reliability of such system is questionable, when used with tissue
processing liquids containing higher concentrations of decontam-
inating agents [13,15,21].
Although the RESEP tube is specifically designed to remove
antibiotics of BASE.128, it eliminated significant amounts of
antibiotic residues from tissue and liquid samples decontaminated
with all investigated cocktails.
In addition, the RESEP tube method allowed ascertaining that
as much as 50% of the tissue samples were contaminated by
bacteria and/or fungi, after decontamination and cryopreserva-
tion. Such contamination was not detected with the direct
inoculum method. Our results confirm that latent contaminations
may be masked by bacteriostatic and fungistatic concentrations of
antimicrobial agents [22]. Validated rinsing procedures to remove
antibiotic residues from tissue samples might enhance bacterial
recovery [23]. The dilution of antibiotics under minimal inhibitory
concentration is an acceptable approach [9–11]; however, it
requires high volumes of growth media in case of high antibiotic
concentrations.
The tissue banks determine allograft microbiological contam-
ination indirectly, through the analysis of tissues samples and
processing liquids. The heart valve banks normally analyze small
pieces (1 cm3) of myocardium, aorta or pulmonary artery, and
processing liquids with volumes ranging from 1 to 5 ml samples at
different processing phases. These amounts usually correspond to
less than 5% of the total tissue or processing liquid sample, and
thus may not properly reflect the contamination profile of the
allograft considering that at least 10% of the total volume for
liquid samples should be tested according to European and US
Pharmacopoeias [9,10]. In fact, we observed that the results
obtained in tissue and related liquid samples did not always match.
This could be partially explained by low volume sampling and/or
low bacterial concentration, at the limit of detection threshold in
tissue, which is mainly expected in brain-dead donors and may
lead to increased variability in results. We also speculated that
there is a heterogeneous distribution of some microbial strains in
specific tissue sites, which were not included among tested samples.
Furthermore, we observed that one contamination was detected
after tissue decontamination, but not after tissue thawing using the
direct inoculum method. This could be due to the sampling
differences described above and/or decrease in the number of
viable microorganisms under the detection threshold of the direct
inoculum method during the last processing phase.
It may be argued that the microbiological positivity observed
only in cryopreserved and the RESEP tube-treated samples could
be a consequence of additional manipulation. However, none of
the control samples undergoing identical manipulations were
contaminated.
Microbiological analysis is closely related to tissue safety as
results are used to determine the suitability of the tissue for
transplantation [11]. Moreover, in case of falsely negative
microbiological results, the inefficacy of the decontamination
procedure is not immediately apparent and can potentially lead to
the release of contaminated tissue, thus compromising the safety of
the allograft recipient [15,22].
The risks deriving from infected tissue transplants have been
extensively documented [24,25] and early postsurgical infections
may have severe clinical implications [15,26]. In addition to
antibiotic prophylaxis used to prevent the risk of surgical site
infection [27,28] and absence of immunosuppressant therapy,
which is not routinely administered in tissue transplantation
[3,29,30], thus maintaining immune defense against possible
pathogens in allograft recipients, the elimination of false negative
tissues could further improve the safety of transplantation
procedures.
The policies concerning the management of microbiologically
contaminated tissues differ considerably among Tissue Banks. Soo
et al. discarded contaminated tissues before antibiotic treatment in
order to not have false negatives, which probably results in higher
than average discard rates [22].
Consistently with other reports [2,14,31], we observed higher
contamination rate in donation after cardiac death donors as
compared with brain-dead donors. This is likely due to agonal
spread and postmortem translocation of microorganisms in
cardiac death donors [31,32], in which the time from death to
cardiectomy is usually longer than that in brain-dead donors [14].
This highlights the need for an efficient decontamination
procedure of tissues from these donors and process validation in
terms of antibiotic cocktail composition, time and temperature
incubation conditions, and related microbiological analysis.
Our data showed that approximately 50% of the cardiovascular
tissues decontaminated by routine methods were microbiologically
positive. Even if no adverse reactions have ever been reported after
transplantation of cardiovascular allograft distributed by our
banks, the results of the present study prompted us to review
and optimize our decontamination protocols and microbiological
methods.
Conclusions
Antibiotic residues present in tissue samples and processing
liquids after decontamination with antibiotic cocktails resulted in a
high rate of falsely negative microbiological analysis. The RESEP
tube method allowed a thorough elimination of residual antibiotics
from tissue and processing liquid samples and a reliable
microbiological assessment of tissue contamination. Although the
results of the present study were observed in a relatively small
False Negative Cardiovascular Tissues Intended for Transplantation
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group of tissues, they demonstrated the need for elimination of
antibiotic residues from tested samples to improve the microbio-
logical methods as required by current pharmacopeias.
Supporting Information
Table S1 Raw data of agar diffusion assays.
(PDF)
Table S2 Supplementary information on microbiologi-
cal analysis.
(PDF)
Author Contributions
Conceived and designed the experiments: JDT AG MB CG GP.
Performed the experiments: MB AG CG SM LD. Analyzed the data:
MB AG CG JDT. Contributed reagents/materials/analysis tools: JDT MB
GP. Wrote the paper: JDT AG MB.
References
1. Jashari R, Van Hoeck B, Ngakam R, Goffin Y, Fan Y (2013) Banking of
cryopreserved arterial allografts in Europe: 20 years of operation in the
European Homograft Bank (EHB) in Brussels. Cell Tissue Bank.14(4): 589–599.
2. de By TM, Parker R, Delmo Walter EM, Hetzer R (2012) Cardiovascular tissue
banking in Europe. HSR Proc Intensive Care Cardiovasc Anesth 4(4): 251–260.
3. Mirelli M, Buzzi M, Pasquinelli G, Tazzari PL, Testi G, et al. (2005) Fresh and
cryopreserved arterial homografts: immunological and clinical results. Trans-
plant Proc 37(6): 2688–2691.
4. Pitt TL, Tidey K, Roy A, Ancliff S, Lomas R, et al. (2014) Activity of four
antimicrobial cocktails for tissue allograft decontamination against bacteria and
Candida spp. of known susceptibility at different temperatures. Cell Tissue Bank
15(1): 119–125.
5. Fan YD, Van Hoeck B, Holovska V, Jashari R (2012) Evaluation of
decontamination process of heart valve and artery tissues in European
Homograft Bank (EHB): a retrospective study of 1,055 cases. Cell Tissue Bank
13(2): 297–304.
6. Jashari R, Tabaku M, Van Hoeck B, Coche´z C, Callant M, et al. (2007)
Decontamination of heart valve and arterial allografts in the European
Homograft Bank (EHB): comparison of two different antibiotic cocktails in
low temperature conditions. Cell Tissue Bank 8(4): 247–255.
7. Gatto C, Giurgola L, D’Amato Tothova J (2013) A suitable and efficient
procedure for the removal of decontaminating antibiotics from tissue allografts.
Cell Tissue Bank 14: 107–115.
8. Saegeman V, Ectors N, Lismont D, Verduyckt B, Verhaegen J (2008)
Bacteriostasis testing on allograft tissue inoculated in Wilkins-Chalgren broth.
J Hosp Infect 70(3): 278–283.
9. European Pharmacopoeia 8th Edition, chapter 2.6.1. Sterility, pp. 175–178.
10. U.S. Pharmacopeia, USP 36, chapter ,71. Sterility tests.
11. Alexander K, Bryans T (2006) Evaluation of the sterility test for detection of
microbial contaminants of allografts. Cell Tissue Bank 7(1): 23–28.
12. Varettas K (2013) Culture methods of allograft musculoskeletal tissue samples in
Australian bacteriology laboratories. Cell Tissue Bank 14(4): 609–614.
13. Schroeter J, Wilkemeyer I, Schiller RA, Pruss A (2012) Validation of the
Microbiological Testing of Tissue Preparations Using the BACTEC Blood
Culture System. Transfus Med Hemother 39: 387–390.
14. Van Kats JP, Van Tricht C, Van Dijk A, Van der Schans M, Van den Bogaerdt
A, et al. (2010) Microbiological examination of donated human cardiac tissue in
heart valve banking. Eur J Cardiothorac Surg 37: 163–169.
15. Kainer MA, Linden JV, Whaley DN, Holmes HT, Jarvis WR, et al. (2004)
Clostridium infections associated with musculoskeletal-tissue allografts.
N Engl J Med 350(25): 2564–2571.
16. Choi KY, Chow LNY, Mookherjee N (2012) Cationic Host defense peptides:
Multifaced Role in Immune Modulation and Inflamation. J Innate Immun 4:
361–370.
17. Brogden NK, Mehalick L, Fischer CL, Wertz PW, Brogden KA (2012) The
emerging role of peptides and lipids as antimicrobial epidermal barriers and
modulators of local inflammation. Skin Pharmacol Physiol 25: 167–181.
18. Huang LC, Petkova TD, Reins RY, Proske RJ, McDermott AM (2006)
Multifunctional roles of human cathelicidin (LL-37) at the ocular surface. Invest
Ophatalmol Vis Sci 47: 2369–2380.
19. Kim JY, Park SC, Lee JK, Choi SJ, Hahm KS, et al. (2012) Novel antibacterial
activity of b(2)-microglobulin in human amniotic fluid. PLoS One 7(11): e47642.
20. Jashari R, Faucon F, Hoeck BV, Gelas SD, Fan Y, et al. (2011) Determination of
Residual Antibiotics in Cryopreserved Heart Valve Allografts. Transfus Med
Hemother 38: 379–386.
21. Mitteregger D, Barousch W, Nehr M, Kundi M, Zeitlinger M, et al. (2013)
Neutralization of antimicrobial substances in new BacT/Alert FA and FN Plus
blood culture bottles. J Clin Microbiol 51(5): 1534–1540.
22. Soo A, Healy DG, El-Bashier H, Shaw S, Wood AE (2011) Quality control in
homograft valve processing: when to screen for microbiological contamination?
Cell Tissue Bank 12(3): 185–190.
23. Pirnay JP, Verween G, Pascual B, Verbeken G, De Corte P, et al. (2012)
Evaluation of a microbiological screening and acceptance procedure for
cryopreserved skin allografts based on 14 day cultures. Cell Tissue Bank 13:
287–295.
24. Eastlund T (1995) Infectious disease transmission through cell, tissue, and organ
transplantation: reducing the risk through donor selection. Cell Transplant 4(5):
455–477.
25. Eastlund T (2006) Bacterial infection transmitted by human tissue allograft
transplantation. Cell Tissue Bank 7(3): 147–166
26. Kuehnert MJ, Clark E, Lockhart SR, Soll DR, Chia J, et al. (1998) Candida
albicans endocarditis associated with a contaminated aortic valve allograft:
implications for regulation of allograft processing. Clin Infect Dis 27(4): 688–
691.
27. Ll Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR (1999)
Guidelines for prevention of surgical site infection. Hospital infection control
Practise advisory committee. Infect Control Hosp Epidemiol 20(4): 250–278.
28. ASHP Therapeutic Guidelines on Antimicrobial Prophylaxis in surgery.
American society of Health system Pharmacists. (1999) Am J Health Syst
Pharm 56(18): 1839–1888.
29. Welters MJ, Oei FB, Vaessen LM, Stegmann AP, Bogers AJ, et al. (2001)
Increased numbers of circulating donor-specific T helper lymphocytes after
human heart valve transplantation. Clin Exp Immunol 124(3): 353–358.
30. Welters MJ, Oei FB, Witvliet MD, Vaessen LM, Cromme-Dijkhuis AH, et al.
(2002) A broad and strong humoral immune response to donor HLA after
implantation of cryopreserved human heart valve allografts. Hum Immunol
63(11): 1019–1025.
31. Tabaku M, Jashari R, Carton HF, Du Verger A, Van Hoeck B, et al. (2004)
Processing of cardiovascular allografts: effectiveness of European Homograft
Bank (EHB) antimicrobial treatment (cool decontamination protocol with low
concentration of antibiotics). Cell Tissue Bank 5(4): 261–266.
32. Morris JA, Harrison LM, Partridge SM (2006) Postmortem bacteriology: a re-
evaluation. J Clin Pathol 59(1): 1–9.
False Negative Cardiovascular Tissues Intended for Transplantation
PLOS ONE | www.plosone.org 6 November 2014 | Volume 9 | Issue 11 | e112679
